A novel fluorescent dye selectively images and kills cancer stem cells by targeting mitochondria: Evidence from a cell line‑based zebrafish xenograft model

Oncol Lett. 2023 Sep 20;26(5):472. doi: 10.3892/ol.2023.14058. eCollection 2023 Nov.

Abstract

Numerous agents such as near-infrared dyes that are characterized by specialized cancer imaging and cytotoxicity effects have key roles in cancer diagnosis and therapy via molecularly targeting special biological tissues, organelles and processes. In the present study, a novel fluorescent compound was demonstrated to inhibit cancer cell proliferation in a zebrafish model with slight in vivo toxicity. Further studies demonstrated selective staining of cancer cells and even putative cancer stem cells via accumulation of the dye in the mitochondria of cancer cells, compared with normal cells. Moreover, this compound was also used to image cancer cells in vivo using a zebrafish model. The compound displayed no apparent toxicity to the host animal. Overall, the data indicated that this compound was worthy of further evaluation due to its low toxicity and selective cancer cell imaging and killing effects. It could be a useful tool in cancer research.

Keywords: cancer stem cell; fluorescent dye; leukemia; mito-chondria; zebrafish.

Grants and funding

The present study was supported by the Project of the Department of Science and Technology of Guangxi Zhuang Autonomous Region, China (grant no. Guike AB19110052), Yunnan Fundamental Research Project (grant no. 202201AT070198) and the National Natural Science Foundation of China (grant no. 82000167).